These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25882186)

  • 1. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
    Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
    J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability.
    Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study.
    Zaal RJ; Ebbers S; Borms M; Koning Bd; Mombarg E; Ooms P; Vollaard H; van den Bemt PM; Evenhuis HM
    Res Dev Disabil; 2016 Aug; 55():132-42. PubMed ID: 27065309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimising psychotropic medication prescribing to reduce adverse drug events.
    Strydom A; Melville C
    J Intellect Disabil Res; 2019 May; 63(5):369-371. PubMed ID: 30993818
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription errors in older individuals with an intellectual disability: prevalence and risk factors in the Healthy Ageing and Intellectual Disability Study.
    Zaal RJ; van der Kaaij AD; Evenhuis HM; van den Bemt PM
    Res Dev Disabil; 2013 May; 34(5):1656-62. PubMed ID: 23501585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities.
    Granas AG; Halvorsen KH; Wendelbo J; Johannessen Landmark C
    Int J Clin Pharm; 2019 Dec; 41(6):1516-1525. PubMed ID: 31729635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
    Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
    Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study.
    Song M; Ware R; Doan TN; Harley D
    J Intellect Disabil Res; 2020 Jan; 64(1):45-56. PubMed ID: 31478300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors.
    García-Domínguez L; Navas P; Verdugo MÁ; Arias VB; Gómez LE
    J Appl Res Intellect Disabil; 2022 Sep; 35(5):1109-1118. PubMed ID: 35384179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
    Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
    J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.